H&H国际控股一季度总收入31.7亿元，同比升10.4%
4月10日，H&H国际控股（01112）发布公告，披露截至2025年3月31日的未审计运营数据。报告期内，公司总收入为31.7亿元，同比上升10.4%（按同类比较基准为上升10.9%），主要受益于中国内地市场的回暖，尤其是婴幼儿配方奶粉业务增长46.9%。成人营养及护理用品分部增长3.2%，而婴幼儿营养及护理用品分部则重拾增长，增幅达到25.3%。此外，宠物营养及护理用品分部也实现了7.3%的增长。
公告还指出，截至2025年3月31日，公司现金余额为14亿元，显示出流动资金的稳健状况。公司积极进行债务再融资，以降低融资成本并延长债务到期时间。同时，关于附属公司Biostime Healthy Australia Pty Ltd的税务审查，澳洲税务局要求其支付2.35亿澳元的主要税项及相关利息和罚款，BHA对此决定表示不认同，并将寻求法律途径进行抗辩。整体来看，公司在2025年展望中将继续推动高利润产品的增长，预计收入将保持正面增长。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10